Liver and biliary tract cancer trials in Portugal
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Faro, Lisbon, Vila Real
- Age
- 18 years to 130 years
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - Phase 3Taking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Almada, Coimbra, Lisbon, Porto
- Age
- 18 years and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Lisbon, Porto
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1Taking peopleA Study of ZW251 in Participants With Advanced Solid Tumors
- Where
- Lisbon, Vila Nova de Gaia
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Zymeworks BC Inc.
See details and how to joinNCT07164313 - Phase 2Taking peopleStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Lisbon
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - Phase 3Taking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Lisbon
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00 - Phase 4Taking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Lisbon
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Lisbon
- Age
- 18 years to 100 years
- People
- 10,000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleHepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
- Where
- Lisbon
- Age
- 18 years to 70 years
- People
- 40
- Run by
- Centro Hospitalar de Lisboa Central
See details and how to joinNCT04499833